4.18 The Clinical Significant of NOTCH1 and MYD88 Mutations in Patients Enrolled onto the UK CLL4 Treatment Trial and in an Early Stage A CLL Cohort

Autor: Rose-Zerilli, M.J., Gonzalez, D., Gomez, B., Parker, H., Gardiner, A., Parker, A., Collins, A., Catovsky, D., Oscier, D.G., Strefford, J.C.
Zdroj: In Clinical Lymphoma Myeloma and Leukemia October 2011 11 Supplement 2:S229-S229
Databáze: ScienceDirect